01—Abstract
Summary
Summary of the 10-Q filed November 2, 2023. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. (ECL) reported strong third quarter and year-to-date results for 2023, demonstrating resilience and growth across its key segments.
Net sales increased by 8% year-over-year for both the quarter and the nine-month period, reaching $3.96 billiona and $11.38 billion, respectively. This growth was driven by a combination of solid pricing actions and modest volume increases, reflecting the company's ability to pass on costs and the demand for its essential products and services. Profitability saw a significant improvement, with reported operating income up 17% in the third quarter and 19% year-to-date.
Diluted EPS also showed robust growth, increasing 17% for the quarter to $1.41b and 17% year-to-date to $3.38. The company's improved gross margin, up to 41.1% in the third quarter from 37.5% in the prior year, highlights effective cost management and pricing strategies. The company also made significant progress on its restructuring programs, driving further efficiencies and contributing to the overall improved financial performance.
02—Key points
Key Highlights
- Net sales increased by 8% to $3.96 billion for Q3 2023 and by 8% to $11.38 billion for the first nine months of 2023, driven by organic growth and pricing.
- Reported operating income increased by 17% to $566.0 million for Q3 2023 and by 21% to $1,402.3 million for the first nine months of 2023.
- Diluted EPS rose by 17% to $1.41 for Q3 2023 and by 17% to $3.38 for the first nine months of 2023.
- Gross margin improved to 41.1% in Q3 2023 from 37.5% in Q3 2022, indicating successful pricing strategies and cost management.
- Organic sales growth was strong across segments: Global Industrial (4% Q3), Global Institutional & Specialty (11% Q3), and Global Healthcare & Life Sciences (11% Q3).
- The company is progressing with its restructuring programs, including the Combined Program and Institutional Advancement Program, which are expected to yield further cost savings.
- Ecolab maintained a strong liquidity position with $1,001.3 million in cash and cash equivalents as of September 30, 2023.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2023, Ecolab Inc. kept $0.10.
- Revenue$3.96B100.0%
- Cost of revenue−$2.33B58.9%
- Gross profit$1.63B41.1%
- Operating costs−$1.06B26.8%
- Operating income$566.0M14.3%
- Interest, other & tax−$162.0M4.1%
- Net income$404.0M10.2%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2023filed November 2, 2023Financial Statements
Q3 FY2023 against Q3 FY2022
| Line item | Q3 FY2023Q3 FY2022 | Change |
|---|---|---|
| Revenue | $3.96B$3.67B | +7.9% |
| Cost of Revenue | $2.33B$2.29B | +1.7% |
| Gross Profit | $1.63B$1.38B | +18.1% |
| SG&A Expenses | $1.02B$876.90M | +16.9% |
| Operating Income | $566.00M$483.00M | +17.2% |
| Interest Expense | $91.30M$66.70M | +36.9% |
| Net Income | $404.00M$347.10M | +16.4% |
| EPS (Basic) | $1.42$1.22 | +16.4% |
| EPS (Diluted) | $1.41$1.21 | +16.5% |
| Shares Outstanding (Basic) | 285.10M284.90M | +0.1% |
| Shares Outstanding (Diluted) | 286.90M286.30M | +0.2% |
05—Questions
Frequently Asked Questions
What is the primary driver of Ecolab's sales growth in Q3 2023?
Ecolab's sales growth in Q3 2023 was primarily driven by a combination of strong pricing actions across its segments and modest volume increases. Organic sales increased by 7% overall, with specific segments like Global Institutional & Specialty and Global Healthcare & Life Sciences showing double-digit growth.
How has Ecolab's profitability changed compared to the prior year?
Profitability has significantly improved. Reported operating income increased by 17% year-over-year for Q3 2023, and diluted EPS grew by 17% to $1.41. This improvement is supported by a strong increase in gross margin to 41.1% and effective cost management.
What is the status of Ecolab's restructuring programs, and what impact are they having?
Ecolab is actively executing its restructuring programs, such as the Combined Program and Institutional Advancement Program, which are focused on cost savings and operational efficiencies. These programs are contributing to improved profitability and are expected to deliver further annualized cost savings in the coming periods.
What is Ecolab's current financial position and liquidity situation?
Ecolab maintains a strong financial position and liquidity. As of September 30, 2023, the company held $1,001.3 million in cash and cash equivalents. Total debt remained stable, and the company is in compliance with its debt covenants, indicating a healthy ability to meet its financial obligations and fund future operations.
06—Continue